Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Pitavastatin in a Real-world Setting

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients in need of statin treatment who are taking or are planning to take Livalo tablets, or who are taking other statins or are planning to change to Livalo tablets.~Exclusion Criteria:~* Patients with hypersensitivity to pitavastatin~* Patients with active liver disease or untranslated transaminase levels Patients with a constant rise in~* Patients with severe liver failure or biliary obstruction and patients with cholestasis~* Patients who are receiving cyclosporine~* Myopathy patients~* Pregnant women or women of childbearing age and lactating women~* Children~* Patients with genetic problems, such as galactose intolerance, Lapp lactose deficiency or glucose-galactose~* Patients deemed inappropriate by the investigator

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).